Replies to post #609515 on NorthWest Biotherapeutics Inc (NWBO)

[Pharmboy46]

I’m just speculating myself, but considering the approximately 300 in the phase 3 trial + maybe 50 in the specials program since the trial ended + maybe 100 compassionate use cases + according to your estimates say 35 people treated with other cancers, we have approximately 485 people treated with DCVAX L?
Am I correct in my assessment that approximately 500 people have received treatment with DCVAX-L?